Disease Outcomes With Ublituximab in Treatment-Naive Participants: Subpopulation Analyses of the Phase 3 ULTIMATE I and II Studies in Participants With Relapsing Multiple Sclerosis

Drug Category: Array
Conference Category: Array
Lead Author: Steinman L, et al.
Published Date: 26/10/2022
Download Link: /wp-content/uploads/2022/10/1055-TGXT-ECTRIMS-2022-Tx-Naive-13Oct22a.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top